TSBX
Turnstone Biologics
TSBX
TSBX
Delisted
TSBX was delisted on the 8th of August, 2025.
47 hedge funds and large institutions have $33.3M invested in Turnstone Biologics in 2024 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 11 increasing their positions, 14 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
less capital invested
Capital invested by funds: $ → $
2.88% less ownership
Funds ownership: 57.79% → 54.92% (-2.9%)
21% less repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 14
Holders
47
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$548K | |
| 2 | +$330K | |
| 3 | +$249K | |
| 4 |
Goldman Sachs
New York
|
+$192K |
| 5 |
ZP
Zimmer Partners
New York
|
+$97.2K |
Top Sellers
| 1 | -$1.63M | |
| 2 | -$1.15M | |
| 3 | -$435K | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$171K |
| 5 |
State Street
Boston,
Massachusetts
|
-$101K |